Targeting β-cell dysfunction as a therapeutic strategy for diabetes: a multi-omics approach
Status
Ongoing
Acronym
No Acronym
Project Reference
2023.01737.BDANA
Start
2024-03-01
End
2028-03-31
Funding Total
0,00 €
Consortium
Participants
- Maria Inês de Jesus Duarte Farrim
Researcher
Researcher
The project aims (a) to provide novel insights on the molecular targets and mechanisms underlying β-cell dysfunction, uncovering molecular targets for potentiating transdifferentiation of α-cells to β-cell-like insulin producers, and (b) to explore the beneficial health effects of small molecule (poly)phenol metabolites (SMPM) in modulating these targets to restore metabolic homeostasis.

FCT